- Why should you buy this report?
- Gain an understanding of the trends shaping and driving gene therapy in oncology in the 8MM
- Analyze various competitor portfolios
- Identify areas of unmet need within the cancer gene therapy market
- Get insights to help plan and design your clinical trials
- Recognize key pricing and reimbursement strategies
What are the gene transfer methods and strategies used in oncology?
GlobalData’s Immuno-oncology market report provides an outline of the current competitive landscape of gene therapies in multiple oncology indications, and covers the late stage clinical development of cancer gene therapies in the 8MM (US, France, Germany, Italy, Spain, UK, Japan and China). The report provides key opinion leader insight on the effect of cancer gene therapies in various treatment paradigms in the oncology space, as well as payer perspective on cost and reimbursement of novel gene therapies.